{"disease":{"id":"pressor-response","name":"pressor response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07164326","title":"Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04441073","title":"Lignocaine Nebulization for Attenuation of Intubation Stress Response","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06592027","title":"Dexmedetomidine for Attenuation of Pressor Response","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Theodor Bilharz Research Institute","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}